Clinical trial
Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo…
NCT00233714 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00233714 |
|---|---|
| Title | Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions |
| Official title | A Randomized Feasibility Study of the Double Dose or Single Dose Sirolimus-Eluting BX VELOCITY Balloon-Expandable Stent for the Treatment of Diabetic Patients With de Novo Native Coronary Artery Lesions(3D) |
| Acronym | 3D |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | CYPHER Sirolimus-Eluting Coronary Stent |
| Enrollment | 56 |
| Start date | May 1, 2003 |
| Primary completion | Jul 1, 2004 |
| Completion | Nov 1, 2009 |
| First posted | Oct 6, 2005 |
| Last update posted | Nov 19, 2009 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: